Monte Carlo Calculation of Radioimmunotherapy with 90Y-, 177Lu-, 131I-, 124I-, and 188Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts
Radioimmunotherapy has shown that the use of monoclonal antibodies combined with a radioisotope like 131I or 90Y still remains ineffective for solid and radioresistant tumour treatment. Previous simulations have revealed that an increase in the number of 90Y labelled to each antibody or nanoobject c...
Main Authors: | S. Lucas, O. Feron, B. Gallez, B. Masereel, C. Michiels, T. Vander Borght |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Computational and Mathematical Methods in Medicine |
Online Access: | http://dx.doi.org/10.1155/2015/284360 |
Similar Items
-
Dosimetry of Radionuclide Therapy with 177Lu-octreotate
by: Sandström, Mattias
Published: (2011) -
Radionuclide generator-based production of therapeutic 177Lu from its long-lived isomer 177mLu
by: Rupali Bhardwaj, et al.
Published: (2019-07-01) -
Deadtime effects in quantification of 177Lu activity for radionuclide therapy
by: Carlos F. Uribe, et al.
Published: (2018-01-01) -
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy
by: Licia Uccelli, et al.
Published: (2017-01-01) -
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
by: Anna Sundlöv, et al.
Published: (2018-07-01)